Adverse Events of Oral GLP-1 Receptor Agonist (Semaglutide Tablets): A Real-World Study Based on FAERS from 2019 to 2023 Si XiongRuoyu GouJunan Chen Original Research Open access 22 May 2024
Addressing the Burden of Multiple Daily Insulin Injections in Type 2 Diabetes with Insulin Pump Technology: A Narrative Review Diana BrixnerSteven V. EdelmanJames R. Gavin III Review Open access 21 May 2024
The Efficacy and Safety of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors in Real-World Clinical Practice: Potential Cautionary Use in Elderly Patients with Type 2 Diabetes (T2D) Dong-Hwa LeeJi Hwan OhTae Keun Oh Original Research Open access 21 May 2024
Urban–Rural Differences in the Prevalence of Diabetes Among Adults in Haryana, India: The ICMR-INDIAB Study (ICMR-INDIAB-18) Sanjay KalraRanjit Mohan AnjanaViswanathan Mohan Original Research Open access 21 May 2024
Analysis of Distribution and Drug Susceptibility Test Results of Pathogenic Bacteria in Diabetic Foot Ulcers Man WuFangting GuoFengxiong Wang Original Research Open access 21 May 2024
Therapy-Related Satisfaction and Quality of Life for Japanese People with Diabetes Using Rapid-Acting Insulin Analogs: A Web-Based Survey Hitoshi IshiiYasutaka MaedaMakoto Imori Original Research Open access 18 May 2024
Efficacy of Self-Review of Lifestyle Behaviors with Once-Weekly Glycated Albumin Measurement in People with Type 2 Diabetes: A Randomized Pilot Study Hideaki JinnouchiAkira YoshidaKoshin Sekimizu Original Research Open access 16 May 2024
Counseling for Insulin Icodec: A Proposed Practitioner’s Guide Sanjay KalraSaptarshi BhattacharyaNitin Kapoor Commentary Open access 14 May 2024
Changes in Basal and Bolus Insulin Requirements with Tirzepatide as an Adjunctive Therapy in Adults with Type 1 Diabetes Using Tandem Control-IQ Kagan E. KarakusMatthew P. KleinViral N. Shah Brief Report Open access 14 May 2024
Could Online Education Replace Face-to-Face Education in Diabetes? A Systematic Review Núria Alonso-CarrilSilvia Rodriguez-RodríguezVerónica Perea Review Open access 14 May 2024
Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational Study David M. WilliamsBarbara-Alex AlbertsThinzar Min Brief Report Open access 09 May 2024
Real-World Treatment Patterns Among Patients with Type 2 Diabetes Mellitus Initiating Treatment with Oral Semaglutide Caroline SwiftMonica S. FrazerMico Guevarra Original Research Open access 09 May 2024
Use of Tirzepatide in Adults with Type 2 Diabetes Mellitus: Scientific Evidence and Practical Aspects Luis A. VázquezSantiago Tofé-PovedanoEsteban Jódar-Gimeno Review Open access 09 May 2024
SPIRIT: Assessing Clinical Parameters Associated with Using IDegLira in Patients with Type 2 Diabetes in a Real-World Setting in Colombia Alex Ramírez-RincónDiana Henao-CarrilloMaría Alejandra Alzate Original Research Open access 08 May 2024
Social Media in the Management of Obesity and Diabetes: An Underutilised Population Educational Tool Frederick KeenBunny BhukyaLyndon M. Evans Commentary Open access 06 May 2024 Pages: 1255 - 1260
Glycemic Control and Body Weight Reduction with Once-Weekly Semaglutide in Colombian Adults with Type 2 Diabetes: Findings from the COLIBRI Study Dagoberto Serpa-DíazCarlos A. Llanos-FlorezMaria A. Alzate-Vinasco Original Research Open access 30 April 2024 Pages: 1451 - 1460
Glycemic Control and Obesity Among People With Type 2 Diabetes in Europe and Australia: A Retrospective Cohort Analysis Rachel S. NewsonVictoria DivinoJulie E. Mount Original Research Open access 29 April 2024 Pages: 1435 - 1449
An Analysis of the Distribution of Direct Cost of Diabetes Care in Selected Districts in Italy Francesco Saverio MenniniPaolo SciattellaUgo Trama Original Research Open access 26 April 2024 Pages: 1417 - 1434
Emerging Perspectives on the Impact of Diabetes Mellitus and Anti-Diabetic Drugs on Premenstrual Syndrome. A Narrative Review Omnia Azmy NabehAlaa AmrSoha Aly Elmorsy Review Open access 26 April 2024 Pages: 1279 - 1299
Podcast on the IWGDF 2023 Guidelines on the Prevention of Foot Ulcers in Persons with Diabetes Sicco A. BusJaap J. Van Netten Commentary Open access 26 April 2024
Exogenous Insulin Antibody Syndrome (EIAS) Presenting in an Elderly, Long-Term Patient with Type 1 Diabetes Mellitus that Resolved with Low-Cost Outpatient Therapy with Mycophenolate Mofetil and Regular Insulin by Pump Terri JerkinsKatherine StockhamDavid S. H. Bell Case Report Open access 24 April 2024 Pages: 1473 - 1481
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial—Study Design and Protocol Peter NovodvorskýLenka ThiemeMartin Haluzík Study Protocol Open access 24 April 2024 Pages: 1461 - 1471
Effect of Luseogliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Dipeptidyl-Peptidase 4 Inhibitors on the Quality-of-Life and Treatment Satisfaction of Patients With Type 2 Diabetes Mellitus: A Subanalysis of a Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT Study) Masahiro FukudaIchiro Sakumaon behalf of the J-SELECT study investigators Original Research Open access 24 April 2024 Pages: 1403 - 1416
Correction to: Effect of Neo-Policaptil Gel Retard on Liver Fat Content and Fibrosis in Adults with Metabolic Syndrome and Type 2 Diabetes: A Non-invasive Approach to MAFLD Giuseppina GuarinoFelice StrolloSandro Gentile Correction Open access 22 April 2024 Pages: 1485 - 1490
Real-World Effectiveness of the Gla-300 + Cap + App Program in Adult Users Living with Type 2 Diabetes in Taiwan Chih-Yuan WangFang L. ZhouJung-Fu Chen Original Research Open access 20 April 2024 Pages: 1389 - 1401
Effects of Two COVID-19 Lockdowns on HbA1c Levels in Patients with Type 1 Diabetes and Associations with Digital Treatment, Health Literacy, and Diabetes Self-Management: A Multicenter, Observational Cohort Study Over 3 Years Daniel TajdarDagmar LühmannIngmar Schäfer Original Research Open access 20 April 2024 Pages: 1375 - 1388
Psychosocial Self-efficacy and its Association with Selected Potential Factors Among Adults with Type 1 Diabetes: A Cross-Sectional Survey Study Divya Anna StephenAnna NordinJan Nilsson Original Research Open access 20 April 2024 Pages: 1361 - 1373
Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study Pierre GourdyPatrice DarmonAlfred Penfornis Original Research Open access 20 April 2024 Pages: 1349 - 1360
Correction to: Use of IDegLira to Intensify, Simplify, and Increase Appropriateness of Type 2 Diabetes Therapy: A Real-Life Experience Isabella RomanoRosalia Serra Correction Open access 18 April 2024 Pages: 1483 - 1483
Barriers to the Use of Insulin Therapy and Potential Solutions: A Narrative Review of Perspectives from the Asia–Pacific Region Roger ChenAzizul Hasan AamirRoopa Mehta Review Open access 16 April 2024 Pages: 1261 - 1277
Neutrophil Extracellular Traps (NETs) Are Associated with Type 2 Diabetes and Diabetic Foot Ulcer Related Amputation: A Prospective Cohort Study Irshat IbrahimYilimire NuermaimaitiYuanquan Wu Original Research Open access 15 April 2024 Pages: 1333 - 1348
Effectiveness, Simplification and Persistence of IDegLira in Poorly Controlled People with Type 2 Diabetes: A 4-Year Follow-Up Real-World Study Chiara Di LoretoRoberta CellenoPaola Del Sindaco Original Research Open access 11 April 2024 Pages: 1313 - 1331
Associations Between HbA1c and Glucose Time in Range Using Continuous Glucose Monitoring in Type 1 Diabetes: Cross-Sectional Population-Based Study Björn EliassonElin Allansson KjölhedeKatarina Eeg-Olofsson Original Research Open access 10 April 2024 Pages: 1301 - 1312
Aberrant Brain Triple-Network Effective Connectivity Patterns in Type 2 Diabetes Mellitus Yujie ZhangXiao YinXindao Yin Original Research Open access 05 April 2024 Pages: 1215 - 1229
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review Samuel SeiduVicki AlabrabaJohn P. H. Wilding Review Open access 05 April 2024 Pages: 1099 - 1124
Summary of Research: Efficacy and Safety of the SGLT2 Inhibitor Empagliflozin Versus Placebo and the DPP-4 Inhibitor Linagliptin Versus Placebo in Young People with Type 2 Diabetes (DINAMO): A Multicentre, Randomised, Double-Blind, Parallel Group, Phase 3 Trial Lori M. Laffel Summary of Research Open access 05 April 2024 Pages: 893 - 896
Effect of Luseogliflozin on Myocardial Flow Reserve in Patients with Type 2 Diabetes Mellitus (LUCENT-J Study) Tamiko TamanahaHisashi MakinoKiminori Hosoda Study Protocol Open access 04 April 2024 Pages: 1245 - 1254
An Obesity-Centric Approach with and Without Anti-Obesity Medications Compared to the Usual-Care Approach to Management of Patients with Obesity and Type 2 Diabetes in an Employer Setting: A Pragmatic Randomized Controlled Trial (EMPOWER-T2D) Kevin M. PantaloneBruce RogenBartolome Burguera Original Research Open access 04 April 2024 Pages: 1201 - 1214
The Current and Future Role of Insulin Therapy in the Management of Type 2 Diabetes: A Narrative Review Janet B. McGillIrl B. HirschJames R. Gavin III Review Open access 04 April 2024 Pages: 1085 - 1098
Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes Robert M. GutgesellRubén NogueirasTimo D. Müller Review Open access 04 April 2024 Pages: 1069 - 1084
Effectiveness of a Lifestyle Improvement Support App in Combination with a Wearable Device in Japanese People with Type 2 Diabetes Mellitus: STEP-DM Study Akiko TakahashiManabu IshiiMakoto Kunisaki Original Research Open access 30 March 2024 Pages: 1187 - 1199
Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity Klara R. KleinTrine J. Abrahamsenon behalf of the N3C Consortium Original Research Open access 27 March 2024 Pages: 1169 - 1186
Validity of Montreal Cognitive Assessment to Detect Cognitive Impairment in Individuals with Type 2 Diabetes Anu GuptaAlpesh GoyalYashdeep Gupta Original Research Open access 23 March 2024 Pages: 1155 - 1168
Adherence and Persistence to Basal Insulin Among People with Type 2 Diabetes in Europe: A Systematic Literature Review and Meta-analysis Esteban J. GimenoMette BøgelundDomingo Orozco-Beltran Review Open access 23 March 2024 Pages: 1047 - 1067
The Why, What and Where Podcast on the Updated 2023 IWGDF Guideline on Offloading Treatments for Diabetes-Related Foot Ulcers Sicco A. BusPeter A. Lazzarini Commentary Open access 23 March 2024
Podcast on How to Classify Foot Ulcers in People with Diabetes (2023 Update of the IWGDF Guidelines on Classification) Matilde Monteiro-SoaresFran Game Commentary Open access 21 March 2024
Evaluating the Safety and Efficacy of Sodium-Glucose Co-transporter 2 Inhibitors in Subjects with Prediabetes: A Protocol for a Randomized Controlled Trial Xiaxuan ZhuLi XiaRui Wei Study Protocol Open access 18 March 2024 Pages: 1231 - 1244
Immediate Impact of Switching from Dipeptidyl Peptidase 4 (DPP4) Inhibitors to Low-Dose (0.3 mg) Liraglutide on Glucose Profiles: A Retrospective Observational Study Sakiko TeruiMari IgariJun Shirakawa Original Research Open access 18 March 2024 Pages: 1139 - 1153
Efficacy and Safety of Tirzepatide in Patients with Type 2 Diabetes: Analysis of SURPASS-AP-Combo by Different Subgroups Yan BiSong LuLinong Ji Original Research Open access 18 March 2024 Pages: 1125 - 1137
Insulin Use During Gestational and Pre-existing Diabetes in Pregnancy: A Systematic Review of Study Design Kristin CastorinoBeatrice OsumiliCarolina Piras de Oliveira Review Open access 18 March 2024 Pages: 929 - 1045